Showing results (401-410 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|February 1, 2021
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosisMara Lecchi, Paolo Verderio, Vera Cappelletti, et al.
Molecular Oncology|January 20, 2021
REST promotes ETS1-dependent vascular growth in medulloblastomaShavali Shaik, Shinji Maegawa, Amanda R Haltom, et al.
Molecular Oncology|January 15, 2021
Circulating tumor cell profiling for precision oncologyMahmoud Labib, Shana O Kelley
Molecular Oncology|February 3, 2021
Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsetsTanja Spethmann, Lukas Clemens Böckelmann, Vera Labitzky, et al.
Molecular Oncology|February 4, 2021
A novel diphtheria toxin-based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinomaZeng Qi, Yue Qiu, Zhaohui Wang, et al.
Molecular Oncology|February 12, 2021
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastasesTesa M Severson, Yanyun Zhu, Angelo M De Marzo, et al.
Molecular Oncology|February 26, 2017
Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cellsUpasana Ray, Shreya Roy Chowdhury, Madavan Vasudevan, et al.
Molecular Oncology|March 16, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitorsVanessa F Merino, Soonweng Cho, Xiaohui Liang, et al.
Molecular Oncology|March 13, 2019
In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53Jolien Van den Bossche, Christophe Deben, Ines De Pauw, et al.
Molecular Oncology|March 13, 2019
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemiaKlaudyna Fidyt, Agata Pastorczak, Agnieszka Goral, et al.
Pageof 258